-
2
-
-
84865767615
-
Consensus statement on the pathology of igg4-related disease
-
Deshpande V, Zen Y, Ferry JA, et al. Consensus statement on the pathology of IgG4-related disease. Mod Pathol. 2012;25(9): 1181-92.
-
(2012)
Mod Pathol
, vol.25
, Issue.9
, pp. 1181-1192
-
-
Deshpande, V.1
Zen, Y.2
Ferry, J.A.3
-
3
-
-
84873736397
-
Effect of baseline rheumatoid factor and anticitrullinated peptide antibody serotype on rituximab clinical response: A meta-analysis
-
Isaacs JD, Cohen SB, Emery P et al. Effect of baseline rheumatoid factor and anticitrullinated peptide antibody serotype on rituximab clinical response: a meta-analysis. Ann Rheum Dis. 2013;329-36.
-
(2013)
Ann Rheum Dis
, pp. 329-336
-
-
Isaacs, J.D.1
Cohen, S.B.2
Emery, P.3
-
4
-
-
77954651554
-
Rituximab compared with cyclophosphamide for remission induction in anca-associated vasculitis
-
Stone JH, Merkel PA, Spiera R, et al. Rituximab compared with cyclophosphamide for remission induction in ANCA-associated vasculitis. N Engl J Med. 2010;363:221-32.
-
(2010)
N Engl J Med
, vol.363
, pp. 221-232
-
-
Stone, J.H.1
Merkel, P.A.2
Spiera, R.3
-
5
-
-
33750291236
-
Treatment of pemphigus vulgaris with rituximab and intravenous immune globulin
-
Ahmed AR, Spigelman X, Cavacini LA, Posner MR. Treatment of pemphigus vulgaris with rituximab and intravenous immune globulin. N Engl J Med. 2006;355:1772-9.
-
(2006)
N Engl J Med
, vol.355
, pp. 1772-1779
-
-
Ahmed, A.R.1
Spigelman, X.2
Cavacini, L.A.3
Posner, M.R.4
-
6
-
-
67649658244
-
M-type phospholipase a2 receptor as target antigen in idiopathic membranous nephropa-thy
-
Beck Jr LH, Bonegio RG, Lambeau G, et al. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropa-thy. N Engl J Med. 2009;361:11-21.
-
(2009)
N Engl J Med
, vol.361
, pp. 11-21
-
-
Beck, L.H.1
Bonegio, R.G.2
Lambeau, G.3
-
7
-
-
84874641528
-
Igg4: A tantalizing connection between membranous glo-merulonephritis and systemic disease
-
Stone JH. IgG4: a tantalizing connection between membranous glo-merulonephritis and systemic disease. Kidney Int. 2012;83: 348-50.
-
(2012)
Kidney Int
, vol.83
, pp. 348-350
-
-
Stone, J.H.1
-
8
-
-
0347994970
-
Autoimmune pancreatitis is a systemic autoimmune disease
-
Kamisawa T, Egawa N, Nakajima H. Autoimmune pancreatitis is a systemic autoimmune disease. Am J Gastroenterol. 2003;98:2811-2.
-
(2003)
Am J Gastroenterol
, vol.98
, pp. 2811-2812
-
-
Kamisawa, T.1
Egawa, N.2
Nakajima, H.3
-
9
-
-
77952919491
-
Rituximab therapy leads to swift decline of serum igg4 levels and prompt clinical improvement in igg4-related disease
-
Khosroshahi A, Bloch DB, Deshpande V, Stone JH. Rituximab therapy leads to swift decline of serum IgG4 levels and prompt clinical improvement in IgG4-related disease. Arthritis Rheum. 2010;62:1755-62.
-
(2010)
Arthritis Rheum
, vol.62
, pp. 1755-1762
-
-
Khosroshahi, A.1
Bloch, D.B.2
Deshpande, V.3
Stone, J.H.4
-
10
-
-
80053385681
-
Cutaneous igg4-related disease
-
Khosroshahi A, Carruthers MD, Deshpande V, Leb L, Reed J, Stone JH. Cutaneous IgG4-related disease. Am J Med. 2011;124:e7-8.
-
(2011)
Am J Med
, vol.124
-
-
Khosroshahi, A.1
Carruthers, M.D.2
Deshpande, V.3
Leb, L.4
Reed, J.5
Stone, J.H.6
-
11
-
-
84855352515
-
Rituximab for the treatment of igg4-related systemic disease: Lessons from a series of ten consecutive cases
-
Khosroshahi A, Carruthers MD, Deshpande V, et al. Rituximab for the treatment of IgG4-related systemic disease: lessons from a series of ten consecutive cases. Medicine (Baltimore). 2012;91:57-66.
-
(2012)
Medicine (Baltimore)
, vol.91
, pp. 57-66
-
-
Khosroshahi, A.1
Carruthers, M.D.2
Deshpande, V.3
|